Tag Archives: CORONA

Galectin-3 identifies subset of heart failure patients who can benefit from a statin

Blood levels of the carbohydrate-binding protein galectin-3 identified patients with ischemic heart failure who derived significant clinical benefit from rosuvastatin in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA) trial. A substudy of CORONA demonstrated that patients with blood levels of galectin-3 <19.0 ng/mL at the start of the… 

Read more »
Posted in Cardiovascular Disease, Pharmacology, Primary Care | Also tagged , , , , , , , , , | Volume: | Leave a comment